Guillaume Wettstein

Guillaume Wettstein has a diverse range of work experience in the field of biology and pharmacology. Guillaume is currently the Head of Biology and Pharmacology at Inventiva Pharma, a position they have held since April 2022. Prior to this, they served as the Head of pharmacology and early projects at the same company from January 2021 to April 2022. From January 2020 to April 2022, Guillaume was the Head of pharmacology, and from January 2018 to January 2021, they were the Head of the fibrosis group. Before joining Inventiva Pharma, Guillaume worked as a Laboratory Head from September 2015 to December 2017, and as a Researcher from February 2015 to August 2015, both at Inventiva Pharma.

In terms of previous companies, Guillaume worked as a Postdoctoral Researcher at Sanofi from November 2012 to April 2014. During their time there, they conducted various studies related to pulmonary fibrosis and tested different drugs and molecules. Prior to that, they worked as a Postdoctoral Researcher at INSERM from January 2012 to June 2012, where they focused on the role of HSP27 in pleuro-pulmonary fibrosis and studied the potential anti-tumoral effect of a molecule derived from Bleomycin. Guillaume also completed their Ph.D. within INSERM from January 2008 to December 2011, where they researched the role of HSP27 in pleuro-pulmonary fibrosis.

In addition to their industry experience, Guillaume has also been involved in various associations and organizations. Guillaume served as the Vice President of the national network BIOTechno from October 2008 to October 2010, where they organized BioTechno days in several cities in France. Guillaume was also the President of the association Edifice from September 2009 to September 2010, where they promoted the skills of Ph.D. students for employment in industry and provided career advice. Furthermore, Guillaume was involved in organizing the forum des jeunes chercheurs, where they were responsible for logistical tasks such as venue arrangements and catering.

Before their industry and association experiences, Guillaume gained research experience as a Research Trainee at the University of Liverpool (Physics department) from March 2007 to August 2007, where they focused on charge transport through a DNA molecule and scanning tunneling microscopy. Guillaume also completed an industrial trainee position at Biom'up from February 2006 to September 2006.

Overall, Guillaume Wettstein has extensive experience in the fields of biology, pharmacology, and fibrosis research, with a strong background in industry and association involvement.

Guillaume Wettstein has a strong educational background in the field of biochemistry and molecular biology. Guillaume obtained a Doctor of Philosophy (PhD) degree from the Université de Bourgogne, specializing in biochemistry, cellular, and molecular biology, from 2008 to 2011. Prior to their PhD, Guillaume pursued a Master's research degree at the University of Liverpool, where they focused on the physical analysis of biological interactions at surfaces, which they completed from 2006 to 2007. Earlier in their academic journey, Guillaume earned a DESS (Diplôme d'Etudes Supérieures Spécialisées) in Technologies and Projets in Biochemistry Engineering from the Université de Bourgogne from 2005 to 2006. Guillaume'seducational foundation in biochemistry began with a master's degree at the same institution, completed in 2004.